While the FDA has approved over 20 different categories of contraceptives, only two are available for men to prevent ...

Women with premenstrual syndrome reported big improvements in their symptoms after taking placebo pills, despite knowing they did not contain any active ingredients ...

Hims & Hers has risen since November 2024, outperforming the S&P 500. Click here to see why HIMS stock is a Buy.

The latest trend in treating hair loss may sound familiar — essentially, it’s a repurposed drug first popularized in the ...

Hims & Hers is shifting towards personalized medicine with AI-backed solutions. Find out why HIMS stock is buyable despite ...

Telehealth company Hims & Hers (HIMS) saw a major boost in app downloads during February. According to a Top-rated analyst, Craig ...

Former US Army Sgt. Mark Millich’s sex drive plummeted — and his genitals shrank and changed shape after taking popular hair-loss drug finasteride.

Within six months, former US Army sergeant Mark Millich began experiencing dizziness, fatigue, cold sweats and was slurring his words - which he described it as feeling 'lobotomized'.

Shares in telehealth business Hims & Hers Health (HIMS) dropped over 6% today after reports that it and peers are marketing ...

To appeal to consumers, Hims pills have bright colors and its chewables undergo taste ... s potential side effects before the ...

Telehealth personalized care company Hims & Hers shuttered a central part of its dermatology offering, skincare brand Apostrophe, to "simplify" its dermatology offerings and operations ...